The animal model market is expected to grow at a CAGR of 8.5% during the forecast period of 2024 to 2032. The identified drivers, including the increasing utilization in cancer research, rising significance in immunological disease studies, and key contributions to infectious disease research, emphasize the pivotal role of animal models in advancing scientific knowledge. The restraint related to ethical and regulatory challenges underscores the industry's responsibility to address ethical considerations and navigate evolving regulatory frameworks. Market segmentation reveals the significance of applications in cancer research and the use of mice as prevalent animal models, providing nuanced insights into the diverse needs of the research community. Geographic trends highlight the dominance of North America and Europe, while competitive trends underscore the importance of technological advancements, strategic collaborations, and product portfolio expansions in maintaining a competitive edge.

Increasing Utilization in Cancer Research

The application of animal models in cancer research has witnessed a substantial increase, evidenced by a surge in research publications and scientific articles highlighting the role of animal models in understanding cancer biology. Academic institutions and research laboratories consistently publish findings that emphasize the crucial contribution of animal models in developing and testing cancer treatments. The highest Compound Annual Growth Rate (CAGR) during the forecast period from 2024 to 2032 is anticipated in this segment, signifying the continued importance of animal models in advancing cancer research.

Rising Significance in Immunological Disease Studies

Animal models have gained prominence in studies related to immunological diseases, as indicated by the growing number of preclinical trials and research projects leveraging animal models to explore the intricacies of immune system disorders. Evidence from scientific conferences and peer-reviewed journals underscores the indispensable role of animal models in advancing our understanding of immunological diseases. The highest CAGR during the forecast period from 2024 to 2032 is expected in this segment, reflecting the increasing recognition of animal models as essential tools in immunology research.

Key Contributions to Infectious Disease Research

Animal models play a crucial role in infectious disease research, demonstrated by their extensive use in testing vaccines, studying disease pathogenesis, and evaluating therapeutic interventions. Evidence from grant funding, collaborative initiatives, and research outcomes underscores the fundamental contributions of animal models in addressing infectious diseases. The highest CAGR during the forecast period from 2024 to 2032 is anticipated in this segment, highlighting the continued reliance on animal models to advance infectious disease studies.

Restraint

Ethical and Regulatory Challenges : Despite the widespread use of animal models, ethical and regulatory challenges pose a significant restraint to their extensive adoption. Evidence from discussions in academic forums, ethical guidelines, and regulatory developments indicates the ongoing concerns and debates surrounding the use of animals in research. The highest CAGR during the forecast period from 2024 to 2032 is expected in this segment, emphasizing the need for ongoing efforts to address ethical considerations and navigate evolving regulatory frameworks. As the industry grapples with these challenges, stakeholders must actively engage in ethical discourse and compliance to ensure the responsible and humane use of animal models.

Market Segmentation by Application: Cancer Research Dominates the Market

In 2023, the animal model market demonstrated significant revenue from applications in cancer research, with this segment leading in both revenue and CAGR. This underscores the critical role of animal models in advancing cancer studies. The highest CAGR during the forecast period from 2024 to 2032 is expected in the category of infectious disease research, highlighting the increasing focus on animal models in addressing global health challenges.

Market Segmentation by Animal Type: Mice Dominates the Market

In 2023, the market witnessed substantial revenue from the use of mice in animal models, with this category leading in both revenue and CAGR. This indicates the prevalent use of mice across diverse research fields. The highest CAGR during the forecast period from 2024 to 2032 is expected in the category of rabbits, showcasing the anticipated growth in the utilization of rabbits as valuable animal models.

North America Remains the Global Leader

With a 49% share of the global market in 2023, North America is projected to maintain a consistent growth rate throughout the forecast. The expansion of the area is ascribed to the existence of influential entities and the implementation of diverse strategic endeavors by them. Additionally, increasing investments in clinical trials and biomedical research contribute to the expansion of the regional market. In addition, the increasing utilization of animal-based models for drug profiling and characterization research, coupled with developments in genetic engineering, is anticipated to generate novel opportunities for market expansion. Asia-Pacific is anticipated to experience the most rapid expansion rate between 2024 and 2032. It is anticipated that the high disease burden associated with chronic conditions, including cancer, immunological disorders, and uncommon genetic disorders, will contribute to the expansion of the regional market. Furthermore, substantial investments made by prominent industry participants in the region, in conjunction with favorable government policies regarding research, constitute an additional element stimulating the expansion of the regional market.

Technological Advancements to Decide on the Market Share

The animal model market's competitive landscape is marked by key players adopting strategies to enhance their market position. Major companies, including Charles River Laboratories, Taconic Biosciences, Envigo, Horizon Discovery Group plc., The Jackson Laboratory, Genoway SA, Eurofins Scientific SE, Crown Bioscience, Inc. and Transposagen Biopharmaceuticals, Inc., have implemented diverse strategies to capitalize on market opportunities. Leading players in the animal model market prioritize technological advancements as a key strategy. Evidence from research collaborations, product launches, and technological investments highlights the industry's commitment to advancing animal model technologies. In 2023, companies like Charles River Laboratories demonstrated significant investments in cutting-edge technologies, positioning themselves at the forefront of innovation in the field. As the market embraces technological enhancements, companies that prioritize research and development are expected to maintain a competitive edge, offering advanced and reliable animal models to researchers worldwide.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Animal Model market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Animal Model market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Animal Model market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Animal Model market?
• Which is the largest regional market for Animal Model market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Animal Model market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Animal Model market worldwide?